A Trial of Point of Care Information in Ambulatory Pediatrics

This study has been completed.
Agency for Healthcare Research and Quality (AHRQ)
Information provided by:
University of Washington
ClinicalTrials.gov Identifier:
First received: August 24, 2006
Last updated: NA
Last verified: August 2006
History: No changes posted
Does presentation of clinical evidence for decision making at point-of-care improve prescribing patterns in ambulatory pediatrics?

Condition Intervention Phase
Acute Otitis Media
Allergic Rhinitis
Device: Electronic point-of-care delivery system
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: A Randomized Clinical Trial to Improve Prescribing Patterns in Ambulatory Pediatrics

Resource links provided by NLM:

Further study details as provided by University of Washington:

Primary Outcome Measures:
  • prescribing practices for acute otitis media,
  • allergic rhinitis,
  • sinusitis,
  • constipation,
  • pharyngitis,
  • croup,
  • urticaria,
  • bronchiolitis

Estimated Enrollment: 44
Study Start Date: November 1999
Estimated Study Completion Date: December 2003
Detailed Description:
We showed previously that an electronic prescription writer and decision support system improved pediatric prescribing behavior for otitis media in an academic clinic setting. This study assessed whether point-of-care evidence delivery could demonstrate similar effects for a wide range of other common pediatric conditions. We performed a randomized controlled trial in a teaching clinic/clinical practice site and a primary care pediatric clinic serving a rural and semi-urban patient mix. There were 36 providers at the teaching clinic/practice site, and 8 providers at the private primary pediatric clinic, and an evidence-based message system presented real time evidence to providers based on prescribing practices for acute otitis media, allergic rhinitis, sinusitis, constipation, pharyngitis, croup, urticaria, and bronchiolitis. We measured the proportion of prescriptions dispensed in accordance with evidence.

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria: The 44 clinical providers at the two participating clinics. -

Exclusion Criteria: Study investigators

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00368823

United States, Washington
Roosevelt Pediatric Clinic
Seattle, Washington, United States
Skagit Valley Pediatrics
Skagit Valley, Washington, United States
Sponsors and Collaborators
University of Washington
Agency for Healthcare Research and Quality (AHRQ)
Principal Investigator: Robert L Davis, MD, MPH University of Washington
  More Information

ClinicalTrials.gov Identifier: NCT00368823     History of Changes
Other Study ID Numbers: HS10516-03 
Study First Received: August 24, 2006
Last Updated: August 24, 2006
Health Authority: United States: Institutional Review Board

Keywords provided by University of Washington:
point of care
evidence based medicine

Additional relevant MeSH terms:
Otitis Media
Rhinitis, Allergic
Bronchial Diseases
Ear Diseases
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Nose Diseases
Otorhinolaryngologic Diseases
Pharyngeal Diseases
Respiratory Hypersensitivity
Respiratory Tract Diseases
Respiratory Tract Infections
Signs and Symptoms
Signs and Symptoms, Digestive
Stomatognathic Diseases

ClinicalTrials.gov processed this record on May 30, 2016